South Wales, July 31 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "SAVANTTE" on July 20. The details about the trademark application no. UK00004418304 published in the journal no. 2026/031 (July 31).

With Mewburn Ellis LLP as representative, Savantte Ltd filed the trademark application for the below mentioned good(s)/service(s).

Class 1 : Diagnostic reagents, assays, agents, and preparations for scientific or research use; diagnostic testing materials for scientific or research use; chemical preparations for testing blood for scientific or research purposes.

Class 5 : Diagnostic reagents, assays, agents, and preparations for medical or veterinary use; diagnostic testing materials for medical or veterinary use; chemical preparations for testing blood for medical or veterinary purposes.

Class 9 : Software for use with diagnostic apparatus, devices, and instruments; software for blood testing and analysis; software for analysing, processing, calculating, displaying and interpreting blood test and diagnostic test results; software for storing, managing, and retrieving blood test and diagnostic test results; software for storing, managing, and retrieving data from diagnostic apparatus and instruments, including patient data, operator data, quality-control data, audit-trail data, and system log data; software for transmitting, communicating, synchronising and integrating blood test and diagnostic test result data with computers, mobile devices, digital devices, databases, healthcare information systems, and electronic medical record systems; software for connecting and exchanging data between diagnostic apparatus, computers, mobile devices, digital devices, databases, and healthcare information systems, electronic medical record systems; software for remote monitoring, management, maintenance, and control of diagnostic apparatus and instruments; software for assisting and supporting clinical decision-making; software for providing recommendations and suggested actions to aid in clinical decision-making; software for processing, calculating, and generating risk scores and alerts from blood test and diagnostic test results; mobile applications for use with diagnostic apparatus, devices, and instruments; mobile applications for blood testing and analysis; mobile applications for analysing, processing, calculating, displaying and interpreting blood test and diagnostic test results; mobile applications for storing, managing, and retrieving blood test and diagnostic test results; mobile applications for storing, managing, and retrieving data from diagnostic apparatus and instruments, including patient data, operator data, quality-control data, audit-trail data, and system log data; mobile applications for transmitting, communicating, synchronising and integrating blood test and diagnostic test result data with computers, mobile devices, digital devices, databases, healthcare information systems, and electronic medical record systems; mobile applications for connecting and exchanging data between diagnostic apparatus, computers, mobile devices, digital devices, databases, and healthcare information systems, electronic medical record systems; mobile applications for remote monitoring, management, maintenance, and control of diagnostic apparatus and instruments; mobile applications for assisting and supporting clinical decision-making; mobile applications for providing recommendations and suggested actions to aid in clinical decision-making; mobile applications for processing, calculating, and generating risk scores and alerts from blood test and diagnostic test results; diagnostic apparatus, not for medical purposes; testing apparatus for diagnostic purposes, not for medical purposes.

Class 10 : Apparatus, devices, and instruments for medical or veterinary diagnosis; apparatus, devices, and instruments for blood testing and analysis for medical or veterinary use; blood testing equipment; single-use diagnostic test cartridges for medical or veterinary use; parts and fittings for the aforesaid.

Class 42 : Software-as-a-service[SaaS] featuring software for use with diagnostic apparatus, devices, and instruments; Software-as-a-service[SaaS] featuring software for blood testing and analysis; Software-as-a-service[SaaS] featuring software for analysing, processing, calculating, displaying and interpreting blood test and diagnostic test results; Software-as-a-service[SaaS] featuring software for storing, managing, and retrieving blood test and diagnostic test results; Software-as-a-service[SaaS] featuring software for storing, managing, and retrieving data from diagnostic apparatus and instruments, including patient data, operator data, quality-control data, audit-trail data, and system log data; Software-as-a-service[SaaS] featuring software for transmitting, communicating, synchronising and integrating blood test and diagnostic test result data with computers, mobile devices, digital devices, databases, healthcare information systems, and electronic medical record systems; Software-as-a-service[SaaS] featuring software for connecting and exchanging data between diagnostic apparatus, computers, mobile devices, digital devices, databases, and healthcare information systems, electronic medical record systems; Software-as-a-service[SaaS] featuring software for remote monitoring, management, maintenance, and control of diagnostic apparatus and instruments; Software-as-a-service[SaaS] featuring software for assisting and supporting clinical decision-making; Software-as-a-service[SaaS] featuring software for providing recommendations and suggested actions to aid in clinical decision-making; Software-as-a-service[SaaS] featuring software for processing, calculating, and generating risk scores and alerts from blood test and diagnostic test results; design and development of diagnostic apparatus; design and development of medical technology; design and development of computer software for use with medical technology.

The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004418304

Disclaimer: Curated by HT Syndication.